More about

Rheumatology

News
September 13, 2019
3 min read
Save

Generation Z ‘coming soon to a workforce near you’ – Are you ready?

Generation Z ‘coming soon to a workforce near you’ – Are you ready?

GRAND RAPIDS, Mich. — Workplaces and managers who may or may not have just grown acquainted with — and successfully integrated — their millennial employees will soon be greeting an entirely new generation, complete with their own priorities and values, according to Lynne Lancaster, BA, of Lynne Lancaster Consulting.

News
September 12, 2019
2 min read
Save

Patients with low-disease RA on tofacitinib, methotrexate can safely withdraw methotrexate

Patients with low-disease RA on tofacitinib, methotrexate can safely withdraw methotrexate

Patients with rheumatoid arthritis who achieve low disease activity with tofacitinib plus methotrexate can safely withdraw methotrexate without fear of worsening disease activity, according to findings published in The Lancet Rheumatology.

News
September 12, 2019
2 min read
Save

Stress ‘primary driver’ for fatigue in patients with SLE

Stress ‘primary driver’ for fatigue in patients with SLE

Although depression and stress are both predictors of fatigue among patients with systemic lupus erythematosus at 1 year, stress is the “primary driver,” and reductions in stress are associated with a clinically meaningful decrease in fatigue, according to findings published in Arthritis Care & Research.

News
September 11, 2019
2 min read
Save

370 medical groups petition Congress for prior authorization reform

370 medical groups petition Congress for prior authorization reform

The American College of Rheumatology has joined 369 other patient, physician and health care professional groups in calling on Congress to pass a bipartisan bill that would amend the Social Security Act to regulate the use of prior authorization for patients with Medicare Advantage plans.

News
September 05, 2019
3 min read
Save

Adalimumab well-tolerated by most children with polyarticular JIA

Adalimumab well-tolerated by most children with polyarticular JIA

Adalimumab, with or without methotrexate, is well-tolerated over a period of at least 7 years among most children with polyarticular-course juvenile idiopathic arthritis, according to data published Arthritis Care & Research.

News
August 17, 2019
3 min watch
Save

'Boilerplate' contract details can be critical game changers for physicians

'Boilerplate' contract details can be critical game changers for physicians

HILTON HEAD, S.C. — Fine print, or “boiler plate” provisions, at the end of a contract can often include critical details that should never be overlooked when finalizing agreements, according to John Michael Durnovich, JD, of Poyner Spruill, in North Carolina.

News
August 16, 2019
7 min read
Save

Arthritis drug market rattles as upadacitinib wins race to FDA approval

Arthritis drug market rattles as upadacitinib wins race to FDA approval

In a landmark FDA approval, AbbVie’s upadacitinib has won the race to enter the drug market as the third JAK inhibitor approved for the treatment of moderate-to-severe rheumatoid arthritis, with the drug expected to be available in the United States within the month.

News
August 15, 2019
2 min read
Save

Rheumatology nurses central to addressing childhood vaccine concerns

Rheumatology nurses central to addressing childhood vaccine concerns

ORLANDO — Although proper vaccination is crucial for all patients with rheumatic diseases, rheumatology nurses who work with children often contend with parental concerns regarding vaccines and must know how best to approach vaccine hesitancy and debunk vaccination myths, according to a presentation at the Rheumatology Nurses Society Annual Conference.

News
August 14, 2019
3 min read
Save

Association of Women in Rheumatology address obstacles, opportunities for female providers

Association of Women in Rheumatology address obstacles, opportunities for female providers

More than 300 registered attendees are expected in Hilton Head, South Carolina, this week for the sixth annual Association of Women in Rheumatology (AWIR) meeting.

News
August 13, 2019
2 min read
Save

Step therapy, insurance exclusions hinder effective drug access in JIA

Step therapy, insurance exclusions hinder effective drug access in JIA

ORLANDO — Treatment of pediatric patients with juvenile idiopathic arthritis with medications available to their adult counterparts is often blocked by exclusions in insurance policies and outdated step therapy requirements, according to a presentation at the Rheumatology Nurses Society Annual Conference.

View more